Last changed on 04 Aprile 2022 - 12:23
The use of photobiomodulation therapy for the prevention of chemotherapy-induced peripheral neuropathy: a randomized, placebo-controlled pilot trial (NEUROLASER trial)

J. Lodewijckx, J. Robijns, M. Claes, S. Evens, L. Swinnen, H. Lenders, S. Bortels, W. Nassen, R. Hilkens, L. Raymakers, S. Snoekx, S. Hermans, J. Mebis
Supportive Care in Cancer, Mar 21;1-9., 2022

Purpose: The purpose of this study was to investigate the effectiveness of photobiomodulation (PBM) therapy for the prevention of chemotherapy-induced peripheral neuropathy (CIPN) in breast cancer patients.